Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2024)
5.2 Diagnosis and Treatment Initiation Trends (2024), by Region
5.3 Gluten-Free Product Adoption and Supplement Usage (2020–2032)
5.4 Healthcare Spending, by Region (Government, Commercial, Private, Out-of-Pocket), 2024
6. Competitive Landscape
6.1 List of Major Companies By Region
6.2 Market Share Analysis By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion Plans and New Product Launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Celiac Disease Treatment Market Segmentation By Treatment
7.1 Chapter Overview
7.2 Vitamins & Minerals
7.2.1 Vitamins & Minerals Market Trend Analysis (2021-2032)
7.2.2 Vitamins & Minerals Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 Gluten-Degrading Enzymes
7.3.1 Gluten Degrading Enzymes Market Trends Analysis (2021-2032)
7.3.2 Gluten Degrading Enzymes Market Size Estimates and Forecasts to 2032 (USD Million)
7.4 Symptomatic Treatment
7.4.1 Symptomatic Treatment Market Trends Analysis (2021-2032)
7.4.2 Symptomatic Treatment Market Size Estimates and Forecasts to 2032 (USD Million)
7.5 Other Treatments
7.5.1 Other Treatments Market Trends Analysis (2021-2032)
7.5.2 Other Treatments Market Size Estimates and Forecasts to 2032 (USD Million)
8. Celiac Disease Treatment Market Segmentation By Distribution Channel
8.1 Chapter Overview
8.2 Hospital Pharmacies
8.2.1 Hospital Pharmacies Market Trends Analysis (2021-2032)
8.2.2 Hospital Pharmacies Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Retail Pharmacies
8.3.1 Retail Pharmacies Market Trends Analysis (2021-2032)
8.3.2 Retail Pharmacies Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 Online Pharmacies
8.4.1 Online Pharmacies Market Trends Analysis (2021-2032)
8.4.2 Online Pharmacies Market Size Estimates and Forecasts to 2032 (USD Million)
8.5 Other Distribution Channels
8.5.1 Other Distribution Channels Market Trends Analysis (2021-2032)
8.5.2 Other Distribution Channels Market Size Estimates and Forecasts to 2032 (USD Million)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Celiac Disease Treatment Market Estimates and Forecasts, by Country (2021-2032) (USD Million)
9.2.3 North America Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.2.4 North America Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.2.5 USA
9.2.5.1 USA Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.2.5.2 USA Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.2.6 Canada
9.2.6.1 Canada Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.2.6.2 Canada Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.2.7 Mexico
9.2.7.1 Mexico Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.2.7.2 Mexico Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.3 Europe
9.3.1 Trends Analysis
9.3.2 Europe Celiac Disease Treatment Market Estimates and Forecasts, by Country (2021-2032) (USD Million)
9.3.3 Europe Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.3.4 Europe Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.3.5 Germany
9.3.5.1 Germany Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.3.5.2 Germany Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.3.6 France
9.3.6.1 France Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.3.6.2 France Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.3.7 UK
9.3.7.1 UK Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.3.7.2 UK Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.3.8 Italy
9.3.8.1 Italy Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.3.8.2 Italy Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.3.9 Spain
9.3.9.1 Spain Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.3.9.2 Spain Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.3.10 Poland
9.3.10.1 Poland Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.3.10.2 Poland Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.3.11 Turkey
9.3.11.1 Turkey Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.3.11.2 Turkey Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.3.12 Rest of Europe
9.3.12.1 Rest of Europe Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.3.12.2 Rest of Europe Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Celiac Disease Treatment Market Estimates and Forecasts, by Country (2021-2032) (USD Million)
9.4.3 Asia Pacific Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.4.4 Asia Pacific Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.4.5 China
9.4.5.1 China Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.4.5.2 China Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.4.6 India
9.4.5.1 India Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.4.5.2 India Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.4.5 Japan
9.4.5.1 Japan Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.4.5.2 Japan Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.4.6 South Korea
9.4.6.1 South Korea Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.4.6.2 South Korea Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.4.7 Singapore
9.4.7.1 Singapore Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.4.7.2 Singapore Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
8.4.8 Australia
8.4.8.1 Australia Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
8.4.8.2 Australia Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.4.9 Rest of Asia Pacific
9.4.9.1 Rest of Asia Pacific Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.4.9.2 Rest of Asia Pacific Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.5 Middle East & Africa
9.5.1 Trends Analysis
9.5.2 Middle East & Africa Celiac Disease Treatment Market Estimates and Forecasts, by Country (2021-2032) (USD Million)
9.5.3 Middle East & Africa Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.5.4 Middle East & Africa Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.5.5 UAE
9.5.5.1 UAE Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.5.5.2 UAE Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.5.6 Saudi Arabia
9.5.6.1 Saudi Arabia Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.5.6.2 Saudi Arabia Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.5.7 Qatar
9.5.7.1 Qatar Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.5.7.2 Qatar Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.5.8 South Africa
9.5.8.1 South Africa Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.5.8.2 South Africa Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.5.9 Middle East & Africa
9.5.9.1 Middle East & Africa Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.5.9.2 Middle East & Africa Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Celiac Disease Treatment Market Estimates and Forecasts, by Country (2021-2032) (USD Million)
9.6.3 Latin America Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.6.4 Latin America Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.6.5 Brazil
9.6.5.1 Brazil Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.6.5.2 Brazil Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.6.6 Argentina
9.6.6.1 Argentina Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.6.6.2 Argentina Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
9.6.7 Rest of Latin America
9.6.7.1 Rest of Latin America Celiac Disease Treatment Market Estimates and Forecasts, By Treatment (2021-2032) (USD Million)
9.6.7.2 Rest of Latin America Celiac Disease Treatment Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Million)
10. Company Profiles
10.1 Takeda Pharmaceutical Company Limited
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Product / Services Offered
10.1.4 SWOT Analysis
10.2 Immunic Therapeutics
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Product/ Services Offered
10.2.4 SWOT Analysis
10.3 Innovate Biopharmaceuticals
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Product/ Services Offered
10.3.4 SWOT Analysis
10.4 BioLineRx Ltd.
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Product/ Services Offered
10.4.4 SWOT Analysis
10.5 Amgen Inc.,
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Product/ Services Offered
10.5.4 SWOT Analysis
10.6 ZEDIRA GmbH
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Product/ Services Offered
10.6.4 SWOT Analysis
10.7 Novartis
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Product/ Services Offered
10.7.4 SWOT Analysis
10.8 Cour Pharmaceuticals
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Product/ Services Offered
10.8.4 SWOT Analysis
10.9 ImmunogenX
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Product/ Services Offered
10.9.4 SWOT Analysis
10.10 Anokion SA.
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Product/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
